Shree Hari Chemicals Export Ltd Hits All-Time High of Rs 286.65 as Momentum Builds Across Timeframes

Robust Price Action and Market Outperformance

The stock opened with a 5% gap up and maintained this elevated level throughout the trading session, signalling strong buying interest. Over the past 13 trading days, Shree Hari Chemicals Export Ltd has delivered an impressive 88.28% return, dwarfing the Sensex’s modest 1.52% gain over the same three-month period. This remarkable run has propelled the stock to a 52-week high of Rs 286.65, a level not seen before in its trading history.

Technically, the momentum appears supportive with the stock trading above all major moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The MACD and Bollinger Bands indicators are bullish on both weekly and monthly charts, while the KST and Dow Theory signals also align positively. However, the RSI on the weekly chart shows bearish tendencies, suggesting some caution may be warranted as the stock approaches overbought territory. Could this divergence between momentum indicators signal a near-term pause or consolidation?

Financial Performance: Earnings and Sales Growth Drive Valuation

The recent quarterly results underpin the stock’s rally. Net sales for the latest six months reached Rs 96.13 crores, reflecting a robust growth rate of 61.97%. Operating profit margins have expanded, with the quarterly PBDIT hitting a record Rs 8.48 crores and the operating profit to net sales ratio reaching 15.44%, the highest on record for the company. Net profit growth has been even more striking, surging 469.23% year-on-year, which helped the company post its highest quarterly PAT of Rs 5.92 crores and EPS of Rs 9.38.

Despite these strong earnings, the return on capital employed (ROCE) remains modest at 6.1% for the half year, indicating that while profitability is improving, capital efficiency has room for enhancement. The company’s promoters have increased their stake by 5.01% over the previous quarter to 64.26%, signalling confidence in the business outlook. Does the combination of strong earnings growth and promoter buying justify the current valuation multiples?

Valuation Metrics: Premium Pricing Amidst Growth

At a price-to-earnings ratio of 15x (TTM), Shree Hari Chemicals Export Ltd trades at a moderate premium relative to typical commodity chemical peers. The price-to-book value stands at 3.89x, while the EV/EBITDA multiple is 12.08x and EV/EBIT at 14.26x. The enterprise value to capital employed ratio of 2.83x suggests the stock is priced richly compared to its capital base. However, the PEG ratio of 0.09x is notably low, reflecting the rapid earnings growth relative to price, which may temper concerns about valuation.

Still, the average ROCE of 11.17% and ROE of 12.62% over the long term are on the weaker side, which raises questions about the sustainability of the current premium multiples. The stock’s dividend yield is negligible, with the last dividend declared at Rs 1 per share in August 2017, indicating that returns to shareholders are primarily through capital appreciation. At these valuations, should you be booking profits on Shree Hari Chemicals Export Ltd or can the company grow into this premium?

Quality and Capital Structure Considerations

The company’s quality metrics present a mixed picture. While sales have grown at a healthy 24.23% CAGR over five years and EBIT growth has been strong at 70.94%, the capital structure is less robust. The average debt to EBITDA ratio of 3.93 and net debt to equity of 0.58 indicate moderate leverage, and the EBIT to interest coverage ratio of 3.62x is relatively weak, suggesting some vulnerability to interest rate fluctuations. On the positive side, there is no promoter share pledging, which reduces governance risk.

Institutional holdings remain low at 0%, which may limit liquidity and broader market participation. The tax ratio of 23.68% is in line with industry norms. Overall, the company is classified as average quality, with growth being the standout feature but capital efficiency and leverage warranting attention. How might these quality factors influence the stock’s ability to sustain its recent gains?

Long-Term Performance and Market Positioning

Over the last decade, Shree Hari Chemicals Export Ltd has delivered a cumulative return of 246.40%, comfortably outperforming the Sensex’s 160.60% gain. The stock’s 5-year return of 380.96% and 3-year return of 451.25% further highlight its strong market performance. Year-to-date, the stock has surged 118.82% while the Sensex has declined nearly 12%, underscoring its resilience in a challenging environment.

Such consistent outperformance is supported by the company’s focus on the commodity chemicals sector, where it has carved out a niche. However, the micro-cap status and relatively low institutional participation suggest that liquidity and volatility remain factors for investors to consider. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of Shree Hari Chemicals Export Ltd to find out.

Key Data at a Glance

Balancing Bull and Bear Perspectives

The rally in Shree Hari Chemicals Export Ltd is supported by strong earnings growth, rising promoter confidence, and technical momentum across multiple timeframes. The stock’s ability to sustain gains above all major moving averages and the bullish MACD and Bollinger Bands signals reinforce the positive price action.

Conversely, the relatively modest ROCE and ROE, moderate leverage, and stretched valuation multiples suggest that caution may be warranted. The bearish RSI on the weekly chart and the stock’s micro-cap status add layers of risk, particularly in volatile markets. At these valuations, should you be booking profits on Shree Hari Chemicals Export Ltd or can the company grow into this premium?

Investors may wish to monitor upcoming quarterly results and any shifts in capital efficiency or leverage to better gauge the sustainability of the current momentum. The interplay between strong growth and valuation premium will likely dictate the stock’s trajectory in the near term.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today